About 4 100 reports

  • Gastrointestinal Drugs Market Key Mergers And Acquisitions
  • Gastrointestinal Drugs Market Trends And Strategies
  • Pathology
  • World
  • Market Size
  • Allergan plc
  • Novo Nordisk Group
  • GASTROINTESTINAL THERAPEUTICS MARKET, GLOBAL, APPROVED GASTROINTESTINAL
  • GASTROINTESTINAL THERAPEUTICS MARKET, GLOBAL, APPROVED GASTROINTESTINAL
  • Pathology
  • World
  • Market Size
  • AstraZeneca PLC
  • Takeda Pharmaceutical Company Limited

Gastrointestinal royalty rates Chapter ## – Leading Gastrointestinal deals and dealmakers ##. ##.

  • Digestive System Disorder
  • Pathology
  • World

Key Features of the Report: - Gastrointestinal Stromal Tumor Patient Flow - Gastrointestinal Stromal Tumor Prevalence - Gastrointestinal Stromal Tumor Diagnosed Patients - Gastrointestinal Stromal Tumor Treated Patients

  • Pathology
  • Europe
  • France
  • World
  • Forecast

Gastrointestinal Stromal Tumors Market Forecast ($), Japan, 2015 – 2020 The latest research from Fore Pharma, Global Gastrointestinal Stromal Tumors Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Gastrointestinal Stromal Tumors pip

  • Pathology
  • France
  • Germany
  • Italy
  • Japan

Key Features of the Report: - Gastrointestinal Stromal Tumor Patient Flow - Gastrointestinal Stromal Tumor Prevalence - Gastrointestinal Stromal Tumor Diagnosed Patients - Gastrointestinal Stromal Tumor Treated Patients

  • Pathology
  • Europe
  • France
  • Germany
  • Forecast

Gastrointestinal Stromal Tumor (GIST) - Epidemiology Forecast to 2027 ##.

  • Pathology
  • France
  • Germany
  • Italy
  • Spain
  • Market definition
  • ECONOMIC BURDEN OF MAJOR DIGESTIVE DISEASES IN THE US 2014 ($ BILLIONS)
  • Pathology
  • World
  • IntroMedic
  • Medtronic, Inc.
  • Olympus Corporation

Gastrointestinal Stromal Tumor (GIST) : ##MM Market Analysis ##. ##. ##MM Market Size of Gastrointestinal Stromal Tumor (GIST) ##. ##. ##MM Percentage Share of drugs marketed for Gastrointestinal Stromal Tumor (GIST) ##. ##. ##MM Market Sales of Gastrointestinal Stromal Tum

  • Cancer
  • Pathology

Gastrointestinal Stromal Tumors Market Forecast ($), UK, 2015 – 2020 The latest research from Fore Pharma, Europe Gastrointestinal Stromal Tumors Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Gastrointestinal Stromal Tumors pipeli

  • Pathology
  • Europe
  • France
  • Germany
  • Italy

Japan Gastrointestinal Stromal Tumors Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Gastrointestinal Stromal Tumors Treatments ##) Gastrointestinal Stromal Tumors Pipeline ##) Japan

  • Cancer
  • Pathology
  • Japan
  • Market Shares

Germany Gastrointestinal Stromal Tumors Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Gastrointestinal Stromal Tumors Treatments ##) Gastrointestinal Stromal Tumors Pipeline ##) Germany

  • Cancer
  • Pathology
  • Germany
  • Market Shares

Italy Gastrointestinal Stromal Tumors Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Gastrointestinal Stromal Tumors Treatments ##) Gastrointestinal Stromal Tumors Pipeline ##) Italy

  • Cancer
  • Pathology
  • Italy
  • Market Shares

France Gastrointestinal Stromal Tumors Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Gastrointestinal Stromal Tumors Treatments ##) Gastrointestinal Stromal Tumors Pipeline ##) France

  • Cancer
  • Pathology
  • France
  • Market Shares

UK Gastrointestinal Stromal Tumors Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Gastrointestinal Stromal Tumors Treatments ##) Gastrointestinal Stromal Tumors Pipeline ##) UK Gastrointestinal S

  • Cancer
  • Pathology
  • United Kingdom
  • Market Shares

US Gastrointestinal Stromal Tumors Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Gastrointestinal Stromal Tumors Treatments ##) Gastrointestinal Stromal Tumors Pipeline ##) US Gastrointestinal S

  • Cancer
  • Pathology
  • Market Shares

Spain Gastrointestinal Stromal Tumors Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Gastrointestinal Stromal Tumors Treatments ##) Gastrointestinal Stromal Tumors Pipeline ##) Spain

  • Cancer
  • Pathology
  • Spain
  • Market Shares
  • 7.2 GASTROINTESTINAL TUMOR MODELS
  • GASTROINTESTINAL TUMOR MODELS IS EXPECTED TO ACCOUNT FOR THE
  • Pathology
  • Forecast
  • Charles River Laboratories International, Inc.
  • Horizon Discovery
  • WuXi AppTec Co.

Welcome to having the world of gastrointestinal cancer at your fingertips with " Target Atlas in Gastrointestinal Cancer: A Competitive Outlook"!

  • Cancer
  • Pathology
  • Digestive/Gastrointestinal System Procedures
  • RISK FACTORS
  • Health Services
  • Hospital
  • Pathology
  • World
  • Forecast
  • SAFETY OF HERCEPTIN MONOTHERAPY IN EARLY-STAGE HER2-POSITIVE BREAST CANCER
  • SAFETY PROFILE OF HALAVEN IN THE THIRD-LINE TREATMENT OF METASTATIC BREAST CANCER

The MTD was not reached during this phase of the trial, and the majority of adverse events were mild or moderate gastrointestinal or hematological toxicities.

  • Pathology
  • Forecast
  • Novartis AG
  • Pfizer Inc.
  • Roche Group
  • GASTROINTESTINAL CANCERS GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
  • BRAIN CANCER GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
  • Pathology
  • World
  • Market Size
  • Accuray Incorporated
  • Elekta Group
  • Global Pharmaceutical Drugs Market, Split By Segments, 2017, $ Billion
  • Global Pharmaceutical Drugs Market, Historic and Forecast, Split By Segment, 2013 - 2021

The gastrointestinal diseases drugs market covers medicines used for the treatment of ulcerative colitis, diverticular disease, perianal infections, anal fissures, hemorrhoids, constipation, and irritable bowel syndrome. li Factors contributing to the size of this market include increasing

  • Pathology
  • World
  • Novartis AG
  • Pfizer Inc.
  • Sanofi S.A.
  • North American Microbiology Testing Market - By Disease Area - Gastrointestinal Infections-
  • Asia-Pacific Microbiology Testing Market - By Disease Area - Gastrointestinal Infections -
  • Pathology
  • World
  • Alere Inc.
  • bioMerieux S.A.
  • Cepheid
  • Market share by therapeutic application 2017
  • Incremental growth % by therapeutic application application (2017-2022)
  • Pathology
  • World
  • Forecast
  • Enterome Bioscience SA
  • Seres Therapeutics, Inc.
  • ALLERGAN: GEOGRAPHICAL SEGMENTATION BY REVENUE 2014

Surgeries for cardiac, renal, and gastrointestinal disorders and cesarean section for childbirth are commonly performed currently.

  • Pathology
  • Allergan plc
  • Bayer AG
  • Merck & Co., Inc.
  • Pfizer Inc.

Gastrointestinal Diseases; ##. ##. ##.

  • Pathology
  • Pharmaceutical
  • Therapy
  • World
  • Market Segment

TECHNAVIO.

  • Pathology
  • World
  • Boston Scientific Corporation
  • Medtronic, Inc.
  • Terumo Corporation

TECHNAVIO.

  • Pathology
  • B. Braun Medical
  • Baxter International Inc.
  • Boston Scientific Corporation
  • Fresenius Group
  • Market drivers

Oral iron has been linked with adverse gastrointestinal side effects and requires the use of multiple doses daily.

  • Pathology
  • World
  • AMAG Pharmaceuticals, Inc.
  • Daiichi Sankyo Company
  • Galenica Group